ConductScience.org, home

Paper39733180

Long-term use of proton pump inhibitors was associated with rapid progression to end stage kidney disease in a Korean nationwide study.

Lee YJ and 4 others. Sci Rep, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Long-term use of proton pump inhibitors was associated with rapid progression to end stage kidney disease in a Korean nationwide study. Papers, record 39733180. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39733180

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term use of proton pump inhibitors was associated with rapid progression to end stage kidney disease in a Korean nationwide study.
PubMed
Journal
Sci Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.81, provisional
iCite
Revised in PubMed
2025-03-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee YJYu Jeong
2Kim JJinmi
3Yu DHDong Han
4Je NKNam Kyung
5Rhee HHarin

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proton Pump InhibitorsMajor topic
Kidney Failure, ChronicMajor topic
Disease ProgressionMajor topic
Humans
Male
Female
Republic of Korea
Aged
Middle Aged
Incidence
Histamine H2 Antagonists
Renal Insufficiency, Chronic
Risk Factors
Proportional Hazards Models
Adult

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
202400620001Biomedical Research Institute Grant Pusan National University HospitalPubMed

Source PubMed

Download CSV of grants

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127082596Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.Medicine (Baltimore)2016https://conductscience.org/library/papers/27082596PubMed
232970396Dapagliflozin in Patients with Chronic Kidney Disease.N Engl J Med2020https://conductscience.org/library/papers/32970396PubMed
331251364Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.QJM2019https://conductscience.org/library/papers/31251364PubMed
426752337Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.JAMA Intern Med2016https://conductscience.org/library/papers/26752337PubMed
524927897Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.Am J Kidney Dis2014https://conductscience.org/library/papers/24927897PubMed
631606235Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.Am J Kidney Dis2020https://conductscience.org/library/papers/31606235PubMed
727487959Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.BMC Nephrol2016https://conductscience.org/library/papers/27487959PubMed
837794003Scalable Infrastructure Supporting Reproducible Nationwide Healthcare Data Analysis toward FAIR Stewardship.Sci Data2023https://conductscience.org/library/papers/37794003PubMed
937420019Proton pump inhibitor use: systematic review of global trends and practices.Eur J Clin Pharmacol2023https://conductscience.org/library/papers/37420019PubMed
1035656154Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research.J Lipid Atheroscler2022https://conductscience.org/library/papers/35656154PubMed
1126389094Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.CMAJ Open2015https://conductscience.org/library/papers/26389094PubMed
1234266395Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.BMC Nephrol2021https://conductscience.org/library/papers/34266395PubMed
1336331190Empagliflozin in Patients with Chronic Kidney Disease.N Engl J Med2023https://conductscience.org/library/papers/36331190PubMed
1432718584Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.Therapie2021https://conductscience.org/library/papers/32718584PubMed
1530419006Correction: Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.PLoS One2018https://conductscience.org/library/papers/30419006PubMed
1628583827Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.Gastroenterology2017https://conductscience.org/library/papers/28583827PubMed
1727080976Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.J Am Soc Nephrol2016https://conductscience.org/library/papers/27080976PubMed
1833368448Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.Br J Clin Pharmacol2021https://conductscience.org/library/papers/33368448PubMed
1938311359Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future.Kidney Res Clin Pract2024https://conductscience.org/library/papers/38311359PubMed
2038269952Health-Analytics Data to Evidence Suite (HADES): Open-Source Software for Observational Research.Stud Health Technol Inform2024https://conductscience.org/library/papers/38269952PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41737121Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis.Cureus2026https://conductscience.org/library/papers/41737121PubMed
41300464In Vivo Studies on the Interaction Between Orally Administered Nitrite and Omeprazole: Beyond Proton-Catalyzed S-Nitrosation.Antioxidants (Basel)2025https://conductscience.org/library/papers/41300464PubMed
41109745Digital Proton Pump Inhibitor Prescribing Education at The Point of Prescription: A Real-World Study in a Primary Care Setting.J Prim Care Community Health2025https://conductscience.org/library/papers/41109745PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39733180

GET https://conductscience.org/api/papers/v1/39733180/authors